Latest information from InnoMedica
May 2022
NEON trial in Parkinson’s patients: Dose escalation completed – Amendment approved to continue treatment for patients …
Read more
March 2022
CLINAM Award 2022 for special achievements in nanomedicine for Stéfan Halbherr and InnoMedica The Scientific Committee of …
First Parkinson’s patients in the NEON study treated On December 14, 2021, the clinical trial (NEON …
May 2021
InnoMedica has reached an important milestone with the submission of the first Clinical Trial Application to …
March 2021
Both the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA) approved InnoMedica’s …
February 2021
InnoMedica is close to submission of the marketing authorization application for its chemotherapy and plans to …
December 2020
In 2020, the InnoMedica team, now counting 39 employees, was able to reach important milestones. The …
October 2020
As a result of the successful financing round of CHF 10 million in April 2020, the …
March 2020
The corona pandemic is a major challenge for everyone. In this context, InnoMedica plans to contribute …
June 2019
The Board of InnoMedica invites all shareholders to attend the Annual General Meeting 2019. The Annual General Meeting …
